Extracellular matrix integrin ligands (ECM integrin ligands)

Extracellular matrix (ECM) integrin ligands at the tumor vasculature are a specialized group of proteins, most notably the EDB and EDA isoforms of fibronectin and the large isoform of tenascin-C, that are overexpressed during tumor-induced angiogenesis (Neri & Bicknell, 2005). These proteins serve as essential ligands for integrin receptors (such as alpha-v beta-3 and alpha-5 beta-1) on activated endothelial cells, facilitating the structural remodeling and signaling required for new blood vessel growth (Schliemann & Neri, 2007). Because these specific ECM variants are virtually absent in normal adult tissues but abundant in the stroma and vasculature of most solid tumors, they represent highly selective targets for precision medicine (Villa et al., 2008). Therapeutic interventions typically utilize recombinant antibodies, such as the L19 or F16 clones, to deliver potent biological effectors like interleukin-2 (IL-2) or tumor necrosis factor (TNF) directly to the tumor site (ClinicalTrials.gov, 2023). This targeted approach aims to maximize the therapeutic index by concentrating the drug's activity within the tumor microenvironment, leading to vascular disruption and the activation of a localized anti-tumor immune response (Gafner et al., 2006).

Other names

Tumor-associated extracellular matrixAngiogenic extracellular matrix ligandsRGD-containing extracellular matrix proteinsFibronectin extra domain B (EDB)Tenascin-C (TNC)Fibronectin extra domain A (EDA)Oncofetal fibronectin

The mechanism involves the high-affinity binding of antibody-based or peptide-based vehicles to specific, alternatively spliced isoforms of ECM proteins (like EDB-fibronectin or Tenascin-C) that are selectively deposited in the sub-endothelial space of neo-vasculature (Neri & Bicknell, 2005). This binding allows for the localized concentration of fused therapeutic payloads—such as proinflammatory cytokines, radionuclides, or cytotoxic agents—directly within the tumor microenvironment, thereby inducing tumor cell death, disrupting the blood supply, and recruiting immune cells while sparing healthy tissues (Schliemann & Neri, 2007; Gafner et al., 2006).